2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with zstk474 in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cushing, TD; McGee, LR; Metz, DP; Whittington, DA | 1 |
Andrs, M; Bartek, J; Hodny, Z; Jun, D; Korabecny, J; Kuca, K | 1 |
Hamilton, JR; Jennings, IG; Mountford, SJ; Sundaram, K; Thompson, PE; Zheng, Z | 1 |
Hamilton, JR; Jackson, SP; Jennings, IG; Mountford, SJ; Nelson, EM; Orive, S; Pinson, JA; Powell, A; Schoenwaelder, SM; Shackleford, D; Thompson, PE; Zheng, Z | 1 |
Duan, HQ; Gan, CC; Jia, M; Jin, MN; Liu, Q; Qin, N; Shou, XA; Wu, XR; Yu, Y | 1 |
Fukui, Y; Gouda, H; Hirono, S; Koshimizu, I; Matsuno, T; Yaguchi, S; Yamazaki, K; Yamori, T; Yoshimi, H | 1 |
Kong, D; Yamori, T | 1 |
Kong, D; Yaguchi, S; Yamori, T | 1 |
Dan, S; Kong, D; Yamazaki, K; Yamori, T | 1 |
1 review(s) available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and zstk474
Article | Year |
---|---|
PI3Kδ and PI3Kγ as targets for autoimmune and inflammatory diseases.
Topics: Animals; Autoimmune Diseases; B-Lymphocytes; Class Ia Phosphatidylinositol 3-Kinase; Class Ib Phosphatidylinositol 3-Kinase; Humans; Inflammation; Isoenzymes; Molecular Targeted Therapy; Neutrophils; Phosphoinositide-3 Kinase Inhibitors; Protein Conformation; T-Lymphocytes | 2012 |
8 other study(ies) available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and zstk474
Article | Year |
---|---|
Phosphatidylinositol 3-Kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors: importance of the morpholine ring.
Topics: Drug Design; Humans; Hydrogen Bonding; Molecular Structure; Morpholines; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Signal Transduction | 2015 |
Class II but Not Second Class-Prospects for the Development of Class II PI3K Inhibitors.
Topics: | 2015 |
Discovery and antiplatelet activity of a selective PI3Kβ inhibitor (MIPS-9922).
Topics: Animals; Drug Discovery; Enzyme Inhibitors; Humans; Male; Mice; Phosphoinositide-3 Kinase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Triazines | 2016 |
Synthesis and anti-metastatic effects of pregn-17(20)-en-3-amine derivatives.
Topics: Amines; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Humans; Inhibitory Concentration 50; Integrin beta1; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-akt; Structure-Activity Relationship | 2016 |
Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.
Topics: Androstadienes; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatin; Chromones; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Immunohistochemistry; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Morpholines; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction; Transplantation, Heterologous; Triazines; Wortmannin | 2006 |
ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms.
Topics: Adenosine Triphosphate; Binding, Competitive; Chromones; Enzyme Inhibitors; Fluoroimmunoassay; Humans; Isoenzymes; Kinetics; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinases; Ribosomal Protein S6 Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Triazines | 2007 |
Effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor, on DNA-dependent protein kinase.
Topics: Chromones; DNA-Activated Protein Kinase; Enzyme Inhibitors; Furans; Imidazoles; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Substrate Specificity; Triazines | 2009 |
Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39.
Topics: Algorithms; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Chromones; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indazoles; Morpholines; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinolines; Substrate Specificity; Sulfonamides; Triazines | 2010 |